Cologne Conference Center
Date: November 7, 2016
Time: 16:00 – 17:00
Stream: Main agenda, Level 2, Room 3
Venture capitalists are the public face of innovative healthcare funding but they also go through fundraising rounds. Who are the people and organizations who ultimately bankroll biotech businesses? What are their markers of success and what do they demand not only of VCs but also of the portfolio companies that VCs invested in?
TVM Capital Life Sience Managing Partner Dr. Hubert Birner moderates this panel looking into asset allocation, fundraising and fund creation processes to shed some light on the discussions that more or less determine the fundraising process of young life science companies. Attend this panel to learn what you always wanted to know about life science funding – but were afraid to ask….
See you in Cologne!